Meso‐dihydroguaiaretic acid and licarin A of Machilus thunbergii protect against glutamate‐induced toxicity in primary cultures of a rat cortical cells

British Journal of Pharmacology - Tập 146 Số 5 - Trang 752-759 - 2005
Choong Je1, So Ra Kim, Jinwoong Kim, Young Choong Kim
1College of Pharmacy and Research Institute of Pharmaceutical Science, Seoul National University, Gwanak-Gu, Seoul 151-742, Republic of Korea.

Tóm tắt

We previously reported that four lignans isolated from the bark of Machilus thunbergii Sieb. et Zucc. (Lauraceae) protected primary cultures of rat cortical neurons from neurotoxicity induced by glutamate. Among the lignans, meso‐dihydroguaiarectic acid (MDGA) and licarin A significantly attenuated glutamate‐induced neurotoxicity when added prior to or right after the excitotoxic glutamate challenge. The neuroprotective activities of two lignans appeared to be more effective in protecting neurons against neurotoxicity induced by NMDA than that induced by kainic acid. MDGA and licarin A diminished the calcium influx that routinely accompanies with the glutamate‐induced neurotoxicity, and inhibited the subsequent overproduction of cellular nitric oxide and peroxide to the level of control cells. They also preserved cellular activities of antioxidative enzymes such as superoxide dismutase, glutathione peroxidase and glutathione reductase reduced in the glutamate‐injured neuronal cells. Thus, our results suggest that MDGA and licarin A significantly protect primary cultured neuronal cells against glutamate‐induced oxidative stress, via antioxidative activities. British Journal of Pharmacology (2005) 146, 752–759. doi:10.1038/sj.bjp.0706380

Từ khóa


Tài liệu tham khảo

10.1016/S0006-8993(98)00064-X

10.1016/S0165-0173(97)00045-3

CACABELOS R., 1996, APOE‐related frequency of cognitive and noncognitive symptoms in dementia, Meth. Find Exp. Clin. Pharmacol., 18, 693

CARLBERG I., 1975, Purification and characterization of the flavoenzyme glutathione redcutase from rat liver, J. Biol. Chem., 250, 5475, 10.1016/S0021-9258(19)41206-4

10.1016/0378-4274(95)80011-2

10.1523/JNEUROSCI.08-01-00185.1988

10.1016/0028-3908(94)90045-0

10.1111/j.1471-4159.1987.tb10014.x

FAROOQUI A.A., 2001, Neurochemical consequences of kainate‐induced toxicity in brain: involvement of arachidonic acid release and prevention of toxicity by phospholipase A2 inhibitors, Brain Res. Brain Res. Rev., 38, 61, 10.1016/S0169-328X(01)00214-5

10.1016/S0076-6879(84)05015-1

GIBSON G.G., 1988, Introduction to Drug Metabolism, 239

10.1006/exnr.1994.1107

10.1046/j.1471-4159.1996.66020637.x

10.1016/S0021-9258(19)83641-4

10.1002/jnr.10828

10.1016/S0891-5849(02)00751-7

10.1038/sj.bjp.0704576

10.1055/s-2004-818964

10.1002/(SICI)1097-4547(19980815)53:4<426::AID-JNR4>3.0.CO;2-8

10.1016/0165-0270(87)90041-0

10.1016/0304-3940(95)12018-Y

10.1038/364535a0

LEE J.M., 1999, The changing landscape of ischaemic brain injury mechanisms, Nature, 399, 7, 10.1038/399a007

LIPTON S.A., 1994, Excitatory amino acids as a final common pathway for neurologic disorders, N. Eng. J. Med., 330, 613, 10.1056/NEJM199403033300907

10.1016/S0021-9258(19)52451-6

10.1055/s-2004-815463

10.1016/S0021-9258(18)63504-5

10.1016/0165-0173(90)90011-C

10.1016/S0301-0082(97)00055-5

10.1016/j.brainresrev.2004.04.001

10.1046/j.1432-1327.2000.01595.x

10.1016/S0165-6147(96)80008-3

10.1016/0003-2697(69)90064-5

10.1016/0041-008X(80)90335-X

10.1211/0022357001774949

Thông tin
Thông tin xuất bản

British Journal of Pharmacology

Tập 146 Số 5

752-759

Thông tin tác giả